You can now review and comment on this draft guideline.
Closing date for comments: Friday 17 February 2023 at 10am
Please note that this guideline is part of a programme piloting new approaches to guideline development at NICE. As part of this, we are trialling a different way of responding to stakeholder comments. The comments received for this consultation may not be responded to individually; instead, we will produce a thematic summary of comments and responses if the comments are suitable for this approach. We will invite feedback on this approach from stakeholders following consultation via a survey.
How to comment:
1. Register your organisation or comment as an individual
If you’re commenting for an organisation, your organisation needs to be registered as a stakeholder.
Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your comments to them.
We can accept comments from individuals. These will be considered, but you won’t get a formal response and they won’t be posted on the NICE website. Wherever possible we encourage you to submit your comments through a registered stakeholder organisation.
2. Read the consultation documents
Documents to comment on:
Supporting documents
Other information about the consultation
3. Add your comments
- You must use this Comments form.
- You must declare any links with, or funding from, the tobacco industry.
If you share similar views with another organisation, send a joint response.
Make sure you consider:
- The areas that will have the biggest impact on practice and be challenging to implement
- How to help users overcome challenges
Developing NICE guidelines: how to get involved suggests some other areas to comment on.
4. Email the form to us
Email: breastcancerupdate@nice.org.uk
Deadline: 17/02/23 at 10am
This page was last updated: